Shots:

• Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21
• The acquisition will accelerate Hologic's global footprints by enabling it to expand into the large- fast-growing acute care adjacency with a near-patient testing solution that offers ease of use- multiplex capability and rapid turnaround time
• Mobidiag offers a broad range of tests and automated platforms including Amplidiag and Novodiag. Additionally- Hologic plans to invest in assay development to promote the growth of the Novodiag platform

  Ref: BusinessWire | Image: Medical Product Outsourcing